MENU
NEO
AS OF
Feb 4, 01:31 PM (EDT)
Price
$11.98
Change
-$0.52 (-4.16%)
Capitalization
1.62B
13 days until earnings call
Intraday BUY SELL Signals
+Compare
NEO
Stock ticker: NASDAQ
AS OF
Feb 4, 01:31 PM (EDT)
Price
$11.98
Change
-$0.52 (-4.16%)
Capitalization
1.62B

NEO NeoGenomics Forecast, Technical & Fundamental Analysis

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology... Show more

NEO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NEO with price predictions
Feb 03, 2026

NEO sees MACD Histogram just turned negative

NEO saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 20, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for NEO moved out of overbought territory on January 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NEO as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where NEO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

NEO moved above its 50-day moving average on February 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

NEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 182 cases where NEO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.931) is normal, around the industry mean (12.114). P/E Ratio (0.000) is within average values for comparable stocks, (121.202). NEO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.874). NEO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.253) is also within normal values, averaging (12.571).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NEO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NEO is expected to report earnings to rise 26.67% to 3 cents per share on February 17

NeoGenomics NEO Stock Earnings Reports
Q4'25
Est.
$0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.01
The last earnings report on October 28 showed earnings per share of 2 cents, beating the estimate of 1 cents. With 202.76K shares outstanding, the current market capitalization sits at 1.62B.
A.I. Advisor
published General Information

General Information

a provider of genetic and molecular testing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
9490 NeoGenomics Way
Phone
+1 239 768-0600
Employees
2100
Web
https://www.neogenomics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIPIX27.790.08
+0.29%
SEI Mid-Cap I (SIMT)
BIECX27.940.05
+0.18%
Brandes International Equity C
USCAX14.16-0.02
-0.14%
Victory Small Cap Stock
MOSLX9.01-0.06
-0.66%
MassMutual Overseas Adm
GQEFX35.42-0.55
-1.53%
GMO Quality IV

NEO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with VCYT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+2.07%
VCYT - NEO
38%
Loosely correlated
+0.21%
NNOX - NEO
37%
Loosely correlated
-0.37%
FLGT - NEO
37%
Loosely correlated
-0.31%
TWST - NEO
37%
Loosely correlated
+13.98%
QTRX - NEO
35%
Loosely correlated
+2.52%
More